📋 ALAMAR BIOSCIENCES, INC. (ALMR) - Financial Results
Filing Date: 2026-05-08
Accepted: 2026-05-08 08:05:16
Event Type: Financial Results
Event Details:
ALAMAR BIOSCIENCES, INC. (ALMR) Reports the reporting period Financial Results
ALAMAR BIOSCIENCES, INC. (ALMR) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 22
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 64586
8 million of net proceeds, after deducting underwriter commissions, discounts and other expenses incurred by the company.The company intends to provide full
year 2026 revenue guidance in conjunction with its second quarter 2026 earnings release in August
About Alamar Biosciences, Inc.Alamar is a commercial
Management Commentary: '"We began 2026 with a record quarter, nearly doubling revenue year over year as our NULISA platform gained rapid global traction among leading academic research and biopharma customers," said Yuling Luo'
📋 ALAMAR BIOSCIENCES, INC. (ALMR) - Financial Results
Filing Date: 2026-05-08
Accepted: 2026-05-08 08:05:16
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
No business developments data available.
Structured Data: